• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常大鼠乳腺上皮细胞生长、分化及凋亡过程中ErbB2(her-2/neu)、ErbB3和ErbB4的变化。

Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells.

作者信息

Darcy K M, Zangani D, Wohlhueter A L, Huang R Y, Vaughan M M, Russell J A, Ip M M

机构信息

Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

出版信息

J Histochem Cytochem. 2000 Jan;48(1):63-80. doi: 10.1177/002215540004800107.

DOI:10.1177/002215540004800107
PMID:10653587
Abstract

Studies were undertaken to examine the natural role of ErbB2, ErbB3, and ErbB4 during the development of normal rat mammary epithelial cells (MECs) in vivo and in vitro. Immunohistochemical analysis demonstrated that mammary gland terminal end buds expressed abundant ErbB2 and ErbB4 but limited ErbB3 in pubescent rats, whereas luminal epithelial cells in nulliparous rats expressed ErbB2, ErbB3, and/or ErbB4. During pregnancy, ductal epithelial cells and stromal cells expressed abundant ErbB3 but limited ErbB2. Although ErbB2 and ErbB3 were downregulated throughout lactation, both receptors were re-expressed during involution. In contrast, ErbB4 was downregulated throughout pregnancy, lactation, and involution. Immunoblotting and immunoprecipitation studies confirmed the developmental expression of ErbB2 and ErbB3 in the mammary gland and the co-localization of distinct ErbB receptors in the mammary gland of nulliparous rats. In agreement with our in vivo findings, primary culture studies demonstrated that ErbB2 and ErbB3 were expressed in functionally immature, terminally differentiated and apoptotic MECs, and downregulated in functionally differentiated MECs. ErbB receptor signaling was required for epithelial cell growth, functional differentiation, and morphogenesis of immature MECs, and the survival of terminally differentiated MECs. Finally, ErbB4 expression did not interfere with functional differentiation and apoptosis of normal MECs.

摘要

开展了多项研究,以考察ErbB2、ErbB3和ErbB4在正常大鼠乳腺上皮细胞(MECs)体内和体外发育过程中的天然作用。免疫组织化学分析表明,青春期大鼠的乳腺终末芽表达丰富的ErbB2和ErbB4,但ErbB3表达有限,而未生育大鼠的管腔上皮细胞表达ErbB2、ErbB3和/或ErbB4。在怀孕期间,导管上皮细胞和基质细胞表达丰富的ErbB3,但ErbB2表达有限。尽管ErbB2和ErbB3在整个哺乳期均下调,但在退化期均重新表达。相比之下,ErbB4在整个怀孕期、哺乳期和退化期均下调。免疫印迹和免疫沉淀研究证实了ErbB2和ErbB3在乳腺中的发育表达以及未生育大鼠乳腺中不同ErbB受体的共定位。与我们的体内研究结果一致,原代培养研究表明,ErbB2和ErbB3在功能不成熟、终末分化和凋亡的MECs中表达,并在功能分化的MECs中下调。ErbB受体信号传导是未成熟MECs上皮细胞生长、功能分化和形态发生以及终末分化MECs存活所必需的。最后,ErbB4的表达不影响正常MECs的功能分化和凋亡。

相似文献

1
Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells.正常大鼠乳腺上皮细胞生长、分化及凋亡过程中ErbB2(her-2/neu)、ErbB3和ErbB4的变化。
J Histochem Cytochem. 2000 Jan;48(1):63-80. doi: 10.1177/002215540004800107.
2
ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation.ErbB3 驱动妊娠和哺乳期乳腺上皮的存活和分化。
Breast Cancer Res. 2017 Sep 8;19(1):105. doi: 10.1186/s13058-017-0893-7.
3
Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells.表皮生长因子(EGF)受体家族成员ErbB2、ErbB3和ErbB4在发育中大脑的生发区以及含有中枢神经系统干细胞的神经球培养物中的表达。
Dev Neurosci. 2000;22(1-2):16-24. doi: 10.1159/000017423.
4
Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.ErbB2、ErbB3和ErbB4在非人类灵长类动物大脑中的广泛表达。
Brain Res. 2007 Mar 30;1139:95-109. doi: 10.1016/j.brainres.2006.11.047. Epub 2007 Feb 5.
5
Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.神经调节蛋白-1仅诱导表皮生长因子受体(ErbB)受体异二聚体伙伴之间的反式磷酸化。
Cell Signal. 2007 Mar;19(3):466-71. doi: 10.1016/j.cellsig.2006.07.020. Epub 2006 Sep 15.
6
ErbB3 is required for ductal morphogenesis in the mouse mammary gland.ErbB3是小鼠乳腺导管形态发生所必需的。
Breast Cancer Res. 2008;10(6):R96. doi: 10.1186/bcr2198. Epub 2008 Nov 18.
7
Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells.乳腺上皮细胞增殖、分化和凋亡过程中表皮生长因子受体表达与功能的选择性变化
Eur J Cell Biol. 1999 Jul;78(7):511-23. doi: 10.1016/S0171-9335(99)80077-6.
8
Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy.妊娠期间大鼠乳腺中ErbB2及其膜内配体Muc4(唾液粘蛋白复合物)的表达、定位及相互作用
J Cell Physiol. 2005 Apr;203(1):44-53. doi: 10.1002/jcp.20200.
9
Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.转基因小鼠乳腺肿瘤细胞中鼠源erbB3与野生型大鼠c-neu之间的功能相互作用。
Breast Cancer Res. 2005;7(5):R708-18. doi: 10.1186/bcr1281. Epub 2005 Jul 6.
10
ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance.ErbB2、ErbB3和ErbB4在上尿路尿路上皮肿瘤中的表达及其预后意义。
J BUON. 2013 Jul-Sep;18(3):653-9.

引用本文的文献

1
The spatiotemporal and genetic architecture of extraoral taste buds in Astyanax cavefish.Astyanax 洞穴鱼的口外味蕾的时空和遗传结构。
Commun Biol. 2024 Aug 6;7(1):951. doi: 10.1038/s42003-024-06635-2.
2
Busting the Breast Cancer with AstraZeneca's Gefitinib.阿斯利康的吉非替尼抗击乳腺癌
Adv Pharmacol Pharm Sci. 2023 Dec 4;2023:8127695. doi: 10.1155/2023/8127695. eCollection 2023.
3
HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer.
HER3:在不同类型癌症中的预后意义、治疗潜力、当前挑战和未来治疗策略。
Cells. 2023 Oct 25;12(21):2517. doi: 10.3390/cells12212517.
4
ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.不同物种乳腺发育过程中 ERBB 受体及其配体:十五个特征探寻作者。
J Mammary Gland Biol Neoplasia. 2023 May 23;28(1):10. doi: 10.1007/s10911-023-09538-w.
5
Network Pharmacology Analysis, Molecular Docking, and Verification Reveal the Action Mechanism of L. in Treating Breast Cancer.网络药理学分析、分子对接及验证揭示L.治疗乳腺癌的作用机制
Evid Based Complement Alternat Med. 2022 Aug 10;2022:5481563. doi: 10.1155/2022/5481563. eCollection 2022.
6
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment.泛 ERBB 抑制增强了 BRAF 抑制剂在黑色素瘤治疗中的作用。
Melanoma Res. 2014 Jun;24(3):207-18. doi: 10.1097/CMR.0000000000000060.
7
HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).HER2/HER3 通过 MTK1(MEKK4)调节细胞外酸化和细胞迁移。
Cell Signal. 2014 Jan;26(1):70-82. doi: 10.1016/j.cellsig.2013.08.043. Epub 2013 Sep 12.
8
Advances in Targeting HER3 as an Anticancer Therapy.靶向HER3作为抗癌疗法的进展
Chemother Res Pract. 2012;2012:817304. doi: 10.1155/2012/817304. Epub 2012 Nov 7.
9
Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu.在大鼠胆管细胞自发体外转化之前,肿瘤特征的积累决定了对激活的 ErbB-2/Neu 的易感性。
Exp Mol Pathol. 2010 Dec;89(3):248-59. doi: 10.1016/j.yexmp.2010.07.005. Epub 2010 Jul 22.
10
Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies.妇科肿瘤学组的转化研究:卵巢癌标志物、特征和新型治疗方法的评估。
Gynecol Oncol. 2010 Jun;117(3):429-39. doi: 10.1016/j.ygyno.2010.01.048. Epub 2010 Mar 16.